Skip to main content
Erschienen in: Supportive Care in Cancer 4/2019

04.01.2019 | Original Article

Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study

verfasst von: María Padilla-Ruiz, Cristóbal Ruiz-Román, Elisabet Pérez-Ruiz, Antonio Rueda, Maximino Redondo, Francisco Rivas-Ruiz

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast cancer is one of the most common diseases, affecting many thousands of women. Although more than 80% of women survive the experience, very few studies have been conducted to examine the question of resilience among long-term survivors of breast cancer. The aim of this study is to describe the clinical and sociodemographic factors that correlate with greater resilience in women survivors of breast cancer, in the Costa del Sol Health Area (Spain).

Methods

Accordingly, a descriptive cross-sectional study was conducted, with respect to 59 survivors of breast cancer, who each completed a questionnaire for analysis according to the Connor-Davidson Resilience Scale (CD-RISC).

Results

The median resilience score was 77 (interquartile range 70–80). The group of patients who had survived for six or more years since the diagnosis had a higher score for total resilience (90: IR 76–92) than those diagnosed more recently (74: IR 65.7–83.7) (p = 0.012). Regarding the patients’ education background, the group with no formal qualifications or only primary studies had a score of 72 (IR 64–84), versus 79 (IR 74–89.7) for the group with higher levels of education (p = 0.016). Of the clinical variables, only the administration of chemotherapy was significantly associated with the score obtained on the CD-RISC scale (p = 0.012).

Conclusions

The results obtained in this study lead us to conclude that sociodemographic and clinical factors have a positive impact on the level of resilience among women resident in the Costa del Sol Health Area and who are long-term survivors of breast cancer.
Literatur
2.
Zurück zum Zitat Barnadas A, Algara M, Cordoba O, Casas A, Gonzalez M, Marzo M, Montero A, Muñoz M, Ruiz A, Santolaya F, Fernandez T (2017) Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish So. Clin Transl Oncol 20:687–694. https://doi.org/10.1007/s12094-017-1801-4 CrossRefPubMedPubMedCentral Barnadas A, Algara M, Cordoba O, Casas A, Gonzalez M, Marzo M, Montero A, Muñoz M, Ruiz A, Santolaya F, Fernandez T (2017) Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish So. Clin Transl Oncol 20:687–694. https://​doi.​org/​10.​1007/​s12094-017-1801-4 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Crespo M, Fernández-Lansac V, Soberón C (2014) Spanish version of the CD-RISC resilience scale for chronic stress situations. Behav Psychol 22:219–238 Crespo M, Fernández-Lansac V, Soberón C (2014) Spanish version of the CD-RISC resilience scale for chronic stress situations. Behav Psychol 22:219–238
22.
Zurück zum Zitat Kim KJ, Conger RD, Elder GHJ, Lorenz FO (2003) Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Dev 74:127–143CrossRefPubMed Kim KJ, Conger RD, Elder GHJ, Lorenz FO (2003) Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Dev 74:127–143CrossRefPubMed
Metadaten
Titel
Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study
verfasst von
María Padilla-Ruiz
Cristóbal Ruiz-Román
Elisabet Pérez-Ruiz
Antonio Rueda
Maximino Redondo
Francisco Rivas-Ruiz
Publikationsdatum
04.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4612-4

Weitere Artikel der Ausgabe 4/2019

Supportive Care in Cancer 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.